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The aim of this investigation is to analyze the psychological differences of patients and
their relatives according to the formers’ post-transplantation anxiety. We used two groups
of participants: transplant patients (n = 166) and close relatives (n = 166). Four
questionnaires were applied: a Psychological Survey (to both groups), the Hospital
Anxiety and Depression Scale, and the Quality of Life Questionnaire (to the transplant
patients), and the Leeds Scales for the Self-Assessment of Anxiety and Depression (to
the relatives). Participants were assessed twice: post-Intensive Care Unit (ICU; when
patients were moved from the ICU to the Transplantation Unit) and post-hospital (one
year after transplant). Results showed that high anxiety in patients just after organ
transplant was related to an increase of anxiety and depression symptoms both in patients
and relatives one year after transplant; it was also related to a decrease in the quality of
life of these patients.
Keywords: organ transplant, anxiety, depression, quality of life
El objetivo de esta investigación es analizar las diferencias psicológicas en pacientes y
familiares en función de la ansiedad post-trasplante. Seleccionamos dos grupos: 166
trasplantados y los 166 familiares más allegados de estos pacientes. Empleamos una
Encuesta Psicosocial (en ambos grupos), la Escala de Ansiedad y Depresión en Hospital
y el Cuestionario de Calidad de Vida (en el grupo de trasplantados) y las Escalas de
Ansiedad y Depresión de Leeds (en el grupo de familiares). La evaluación psicológica
se realizó en dos fases: post-UCI (cuando a los pacientes se les daba el alta de la UCI
pero continuaban ingresados en el hospital, concretamente, en la Unidad de Trasplantes)
y post-hospitalaria (cuando transcurría un año del alta hospitalaria de los pacientes tras
el implante). Los resultados mostraron que un nivel alto de ansiedad en los pacientes
tras el trasplante, aumentaba al año la sintomatología ansiosa y depresiva de los pacientes
y de sus familiares y, además, empeoraba la calidad de vida de los trasplantados.
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Organ transplant is a therapeutic alternative that offers
patients more quantity and quality of life. However, it must
be taken into account that not all patients attain better
physical, psychological, and social well-being. For example,
in an investigation carried out with liver transplant patients,
it was found that 60% of the patients considered that their
life had not become normalized after transplantation, mainly
due to the presence of diverse physical and psychological
problems: secondary effects of medication, fatigue,
gastrointestinal problems, osteoporosis, and depression
(Holzner et al., 2001). Along these lines, in a review by
Pérez, Martín, and Galán (2005), the authors concluded that
transplant patients could suffer from various psychological
complications, such as: immediate post-operation delirium
caused by immunosupressor medication, sexual disorders
caused either by physical (the disease itself or the
medication) or psychological factors (fear of harming the
transplanted organ), mood disorders that decrease post-
operation adherence to treatment and that can cause organ
rejection, anxiety disorders, especially when patients are
discharged, fantasies about the donor that can lead to feelings
of guilt because they think the donor died so they could
live, and dissatisfaction with body image, because they
perceive the organ as a foreign object that transfers the
donor’s traits to them. Other studies have attempted to
identify the most stressful situations for patients, which can
have negative consequences on their evolution: for example,
uncertainty about their future health, secondary effects of
medication, limitations associated with their physical status,
and medical prescriptions (Achille et al., 2004; Dew,
Myaskovsky, Switzer, DiMartini, & Kormos, 2005).
However, it must be remembered that the transplantation
process also affects the relatives, both in the stage
immediately after transplantation—for example,  adaptation
to the therapeutic prescriptions and recovery from surgery—
and long-term—for example, the possibility of patients’
chronic organ rejection and fear of their dying (Collins,
White, & Jalowiec, 2000). All of this affects the caregivers’
mental health, so that various anxiety and depressive
disorders may appear in them (Dew et al., 2004).
Among the factors that determine the psychological well-
being of transplant patients and their relatives, the studies
have focused on the influence of social support (Frazier,
Tix, Klein, & Arikian, 2000; Wang, Chang, Shih, Sun, &
Jeng, 2006), hospitalization (Dew, DiMartini, et al., 2000;
Pérez, Martín, Asián, & Pérez, 2004), pre- and post-
transplantation expectations (Pérez, Martín, Gallego, &
Santamaría, 2000), coping strategies (Christensen, Raichle,
Ehlers, & Bertolatus, 2002), the duration of the disease
(Owen, Bonds, & Wellisch, 2006; Trumper & Appleby,
2001), the etiology of the transplantation (Gledhill et al.,
1999), and the source of the transplanted organ (Watanabe
& Higara, 1999). However, there has been little research
that has analyzed the psychological differences in the patients
and their relatives as a function of the post-transplantation
anxiety experienced by the patients themselves. This kind
of studies is necessary, among other reasons, to determine
the efficacy of the medical intervention, improve clinical
decisions, control patients’ evolution in their physical,
functional, psychological, and social aspects, understand the
quality of life of the patients and their main caregivers, and
to program psychosocial interventions and rehabilitation
(Moreno & Kern, 2005; Myaskovsky et al., 2005; Ortega
& Rebollo, 2004). Hence, the purpose of this study is to
analyze the psychological differences in patients (anxiety,
depression, and quality of life) and their relatives (anxiety
and depression) as a function of the level of anxiety (high
or low) experienced by the patients shortly after the
transplant surgery carried out one year ago. 
Method
Participants
Two groups that had no psychological and/or psychiatric
antecedents were selected: 166 patients who were on the
waiting list to receive the first transplant of liver, kidney,
or heart, from a deceased donor in the Hospital Universitario
Virgen del Rocío de Sevilla [University Hospital of the
Virgen del Rocío of Seville] and 166 close relatives of these
patients (only one relative for each transplant patient).
The transplant group was made up of 69.27% males and
30.73% females, mean age 48.91 years (SD = 11.22 years,
range = 20-68). With regard to the type of transplanted
organ, there was a predominance of liver transplantations
(47%), followed by kidneys (42.8%), and hearts (10.2%).
Mean stay in hospital was 8.06 days in the Intensive Care
Unit (ICU) for Transplantations and 17.88 days in the
Transplantation Unit of the hospital. The 166 transplanted
organs proceeded from people who had died due to the
following causes: cerebrovascular accidents (53.7%),
traumatic brain injury (40.2%), and others (6.1%).
The group of relatives was made up of 25% males and
75% females, mean age 43.65 years (SD = 13.18 years,
range = 18-76). Their kinship with the patients was: spouse
(56.8%), son/daughter (21.9%), sibling (11%), parent (8.9%),
and other (1.4%). There was a predominance of relatives
who lived with the patients (81.4%), and, in most cases,
their relationship was good (95.2%).
Instruments
Psychosocial Survey: This was elaborated by the authors
and adapted to the characteristics of the two groups
(patients and relatives) used in this study. It collects
sociodemographic data (sex, age, sociocultural and
economic level, etc.), medical data (etiology of the
transplantation, rejection episodes, etc.), psychological data
(expectations towards the disease, experience of highly
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stressful life events, etc.), and family data (whether or not
the patient and the relative lived together, the kind of
relationship they had, etc.). 
The Hospital Anxiety and Depression Scale (HAD;
Zigmond & Snaith, 1983). The traditional measures of
affective alterations contain items that can reflect both
symptoms of a disease and anxious and depressive
manifestations. This led Zigmond and Snaith to develop the
HAD, whose content excludes somatic symptoms of anxiety
and depression (insomnia, fatigue, loss of appetite, etc.),
thus precluding erroneous attribution when applied to patients
who suffer from physical diseases. It has 14 items, 7
referring to depression and 7 to anxiety, inquiring about the
way the person has felt for the last week. Respondents
choose one response from four response possibilities. The
test provides two scores, one for Anxiety and one for
Depression. In both cases, scores are classified as: normal
(0-7 points), doubtful (8-10 points), and clinical cases (≥
11 points). This questionnaire has been widely used in the
Spanish population, and has been adapted by various authors.
We used the version by Caro and Ibáñez (1992). The study
of Tejero, Guimera, Farré, and Peri (1986), with psychiatric
patients in Spain, obtained an alpha coefficient of .81 for
the subscale of Anxiety and of .82 for Depression. The
correlation of the Anxiety subscale with the State scale of
the State-Trait Anxiety Inventory (STAI; Spielberger,
Gorsuch, & Lushene, 1970) was .71 and the correlation of
the Depression subscale with the Beck Depression Inventory
(BDI; Beck, Rush, Shaw, & Emery, 1979) was .74. The
main limitation is that both subscales are somewhat
correlated (r = .59) and, therefore, they are not completely
independent.
The Quality of Life Questionnaire (QLQ-C30;
European Organization for Research and Treatment of
Cancer [EORTC]). This instrument was created by the
Group of Quality of Life of the  EORTC. The test’s
psychometric adequacy, along with its extensive use, has
led to its application beyond the population for which it
was designed. For example, it has been satisfactorily used
with people infected with HIV or AIDS (De Boer, Van
Dam, & Sprangers, 1995) and it was used as a foundation
to construct a questionnaire for chronically ill people
(Rodríguez, Pastor, & López, 1993). It is made up of 30
items with various response formats: (a) yes/no for the
first 7 items; (b) for items 8-28, Likert-type scores range
from 1 (not at all) to 4 (very much); and (c) for the last
2 items, Likert scores range between 1 (very poor) and 7
(excellent).  The questionnaire has five functional scales:
Physical Functioning, Role Functioning, Social
Functioning, Emotional Functioning, and Cognitive
Functioning. It also has a Global Health scale, three
Symptom scales (Fatigue, Pain, and Nausea-vomiting),
and some individual items that reflect difficulties caused
by the illness or its treatment (dyspnea, insomnia, loss of
appetite, constipation, diarrhea, and financial impact). The
questionnaire was validated in a Spanish sample by
Arrarás, Illarramendi, and Valerdi (1995), and the result
of factor analysis was in accordance with the structure of
most of the scales. Seven scales presented alpha
coefficients between .65 and .85, and two values below
.60.  Osoba, Zee, Pater, Warr, and Latreille (1994) reported
a global internal consistency of .78 (alpha), and a criterion
validity of .85 when correlating the scale with the Eastern
Cooperative Oncological Group scale. 
The Leeds Anxiety and Depression Scales (Snaith,
Bridge, & Hamilton, 1976). This instrument was created
from the 12 original items of the Wakefield Self-Assessment
of Depression Inventory (Snaith, Ahmed, Mehta, &
Hamilton, 1971) to which another 10 items were added; 2
of them from the Anxiety Scale of the Symptom Rating
Tests (Kellner & Sheffield, 1973). The final version
comprised 22 items with four response alternatives (very
often, sometimes, not often, and never) from which
respondents selected one. In addition to providing a Total
Anxiety-Depression score, the test provides five other
scores: Specific Anxiety, Specific Depression, Differential
Score, General Anxiety, and General Depression. In the
original study of Snaith et al., the psychometric data were
established from a sample of psychiatric patients with
anxious and depressive pathologies who self-rated
themselves on the 22 items of the scale. In order to obtain
external reference scores, these patients were also assessed
with the Hamilton Anxiety and Depression Scales
(Hamilton, 1959, 1967). When considering the sample of
items conjointly, an item was assigned either to the Anxiety
or the Depression scale if it correlated higher than .52 with
the appropriate external observation rating (anxiety or
depression) and its contribution to the variance differed by
at least .05 from the correlation of the item with the two
reference assessments (anxiety and depression). Lastly, in
the crossed validation study, the correlation of the General
Depression scale with the observers’ estimation was .85 (p
< .01), and that of the General Anxiety scale was .83 (p <
.01). This scale has also been used in Spain in investigations
with samples of cardiovascular patients (Bueno & Buceta,
1997; Garces, Velandrino, Conesa, & Ortega, 2002).
Likewise, this scale is being validated by the authors of
the present investigation. 
Procedure
Before beginning the assessment of the participants, we
provided information about the investigation, we clarified
all their doubts, and they provided written informed consent.
They were informed that their participation was voluntary
and they could leave the study whenever they wanted to
without having to offer any explanations, and this would
not affect their medical care. 
The transplant patients and their relatives were assessed
at two different times: 
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Post-ICU Phase. At this time, we administered the HAD
(Zigmond & Snaith, 1983) to the patients, who, after
undergoing transplantation surgery, were discharged from the
ICU but remained hospitalized in the Transplantation Unit.
Diverse sociographic and medical data were obtained with
the psychosocial survey, administered both to patients and
their close relatives. All the participants (patients and relatives)
had a week in which to adapt to the conditions and
circumstances of hospitalization before undergoing assessment. 
Post-Hospital Phase. Exactly one year after they had
been discharged, the transplant patients completed the HAD
(Zigmond & Snaith, 1983) again, and the Quality of Life
Questionnaire (the version by Arrarás et al., 1995), whereas
their relatives completed the Leeds Anxiety and Depression
Scales (Snaith et al., 1976).
According to the classification of Montero and León
(2005), this study is a simple prospective ex post facto study.
The transplant sample was selected from among 255 patients
who were admitted to the hospital during a two-year interval
to undergo surgery to receive organ transplantation. When
selecting the sample, all the patients had undergone surgery
and were hospitalized in the Transplantation Unit (liver, kidney,
or heart) after having stayed for some time in the ICU. 
Four inclusion criteria were taken into account when
selecting the patients: (a) 18 years of age or older; (b)
sufficient cognitive capacity to complete the
questionnaires, that is, they did not present sensory or
mental alterations that prevented spatial-temporal
orientation or maintaining a congruent conversation; (c)
providing written informed consent to participate in the
study; and (d) having received a first organ transplantation
(liver, kidney, or heart) from a deceased donor. Out of
the original group, 166 patients fulfilled these criteria.
However, 35 patients dropped out in the post-hospital
phase. The main reasons were: (a) 16 patients had died
at follow-up, most of them due to an acute rejection of
the organ and subsequent multi-organic failure, and (b)
19 patients and/or their relatives did not wish to
collaborate in the second phase of this study. 
Statistical Analyses
In order to analyze the psychological differences of the
patients and their relatives as a function of the level of post-
transplantation anxiety experienced by the patients, we
carried out the following steps: 
Table 1
Psychological Differences (Anxiety, Depression from the HAD and Quality of Life from the QLQ) in Transplant Patients
as a Function of their Post-Transplantation Anxiety One Year Ago
Post-Transplant Anxiety
Low High                    
Variables measured one year after Transplantation M   (SD)                  M (SD)       Value of Contrast Statistic p
HAD Scale
Total Anxiety Score 4.27  (4.42) 6.64  (3.29) t(84) = –2.841 .006**
Total Depression Score 2.68  (3.38) 4.18  (3.95) U = –2.020 .043*
QLQ Variables
Physical Functioning 0.79  (0.23) 0.80  (0.18) U = –0.161 .872
Role Functioning 0.71  (0.40) 0.61  (0.43) U = –1.030 .303
Social Functioning 1.35  (0.62) 1.72  (0.82) U = –2.429 .015*
Emotional Functioning 1.60  (0.75) 1.87  (0.55) U = –2.714 .007**
Cognitive Functioning 1.48  (0.73) 1.66  (0.75) U = –1.447 .148
Global Health Scale 5.43  (1.37) 5.14  (1.29) t(84) =  0.985 .328
Fatigue 1.63  (0.72) 1.85  (0.67) U = –1.689 .091
Pain 1.59  (0.91) 1.46  (0.67) U = –0.309 .757
Nausea-vomiting 1.15  (0.44) 1.12  (0.30) U = –0.332 .740
Dyspnea 1.24  (0.43) 1.38  (0.57) U = –1.079 .281
Insomnia 1.52  (0.74) 1.76  (0.87) U = –1.297 .195
Loss of appetite 1.19  (0.63) 1.30  (0.55) U = –1.805 .071
Constipation 1.24  (0.61) 1.87  (0.95) U = –3.690 .000**
Diarrhea 1.40  (0.76) 1.29  (0.58) U = –0.671 .502
Financial impact 1.43  (0.95) 1.84  (1.07) U = –2.403 .016*
Note. Higher scores indicate higher identification with the variable and/or poorer functioning, except for the variables Physical Functioning
and Role Functioning, in which higher scores indicate better functioning. 
*  p ≤ .05. ** p < .01.
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Firstly, after they had undergone surgery and had
remained in the Transplantation Unit of the hospital, the
patients’ were divided into two subgroups (high and low
post-transplantation anxiety) as a function of their Total
Anxiety scores on the HAD (Zigmond & Snaith, 1983).
Specifically, the low post-transplantation anxiety group
comprised 61 transplant patients with scores equal to or
lower than 46.6%, that is, a total score of 5 points or less.
The 70 patients with scores higher than 46.6%, that is, scores
over 5 points, made up the high post-transplantation anxiety
subgroup. 
Secondly, to compare the differences one year after
discharge in patients’ and relatives’ anxious and depressive
symptomatology and quality of life in both patient subgroups
(high and low post-transplantation anxiety), the following
analyses were conducted: (a) first, we applied the normality
test (Kolmogorov Smirnov test) to the 17 variables of interest
assessed by the HAD and the QLQ in the patients (total
anxiety score, total depression score, physical functioning,
role functioning, social functioning, emotional functioning,
and cognitive functioning, global health, fatigue, pain, and
nausea-vomiting, dyspnea, insomnia, loss of appetite,
constipation, diarrhea, and financial impact) and in the 6
variables assessed with the Leeds Anxiety and Depression
Scales in the relatives (total anxiety-depression score, specific
anxiety, specific depression, differential score, general anxiety
and general depression); and (b) then, we applied Student’s
t test to the variables with a normal distribution and the
Mann-Whitney U test to the variables that did not have a
normal distribution. 
Results
In the transplant patients, the following variables were
statistically significant:  total anxiety score, total depression
score, social and emotional functioning, constipation, and
financial impact, in which the patients who had higher
previous levels of post-transplantation anxiety scored
significantly higher (see Table 1). We then analyzed the
items of all these variables (except for constipation and
financial impact, which were individual items) to detect
those that were more relevant in accounting for the
differences. The items that reached the highest significance
were related to the emotional sphere. More specifically,
transplant patients with higher levels of post-transplantation
Table 2
Analysis of Items from the HAD (Anxiety, Depression) and the QLQ (Quality of Life) in Transplant Patients as a Function
of their Post-Transplantation Anxiety One Year Ago
Post-Transplant Anxiety
Low High                    
Items Assessed One Year Later M   (SD)             M (SD)     Value of Mann-Whitney U Statistic p
HAD Items
Total Anxiety Score: 
I feel tense or wound up 0.75  (0.83) 1.06 (0.60) –2.719 .007**
I get a sort of frightened feeling as if 
something awful is about to happen 0.57  (0.84) 1.02 (0.73) –3.166    .002** 
Worrying thoughts go through my mind 0.68  (0.98) 1.17 (1.00) –2.466 .014* 
I feel restless as if I have to be on the move 0.69  (0.95) 0.98 (0.81) –2.099 .036* 
I get sudden feelings of panic 0.29  (0.75) 0.76 (0.67) –3.855 .000**
Total Depression Score: 
I feel cheerful♦ 0.34  (0.64) 0.72 (0.90) –2.280 .023*
I look forward with enjoyment to things♦ 0.24  (0.53) 0.53 (0.75) –2.060 .039*
QLQ Items
Social functioning:  
Has your physical state or medical treatment 
affected your family life? 1.29  (0.60) 1.68 (0.85) –2.404 .016*
Has your physical state or medical treatment 
affected your social activities? 1.37  (0.79) 1.73 (0.89) –2.465 .014*
Emotional Functioning:  
Have you felt nervous? 1.77  (0.92) 2.09 (0.78) –2.198 .028*
Have you felt depressed? 1.31  (0.64) 1.75 (0.83) –2.920 .004**
Note. Higher scores indicate higher degree of agreement with the item (except for items from the Total Depression Score—marked with
♦—where lower scores indicate more agreement with the item) and/or poorer functioning.
*p ≤ .05. **p < .01.
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Table 3
Relatives’ Differences in Anxiety and Depression as Measured with the Leeds Anxiety and Depression Scales as a Function
of Transplant Patients’ Post-Transplantation Anxiety One Year Ago
Post-Transplant Anxiety
Variables from the Leeds Anxiety and Depression    Low High                    
Scale one Year after Transplantation M   (SD)                  M (SD)        Value of Contrast Statistic p
Total Anxiety-Depression Score 15.76  (10.68) 23.44  (13.48) U = –2.789 .007**
Specific Anxiety 3.51  (3.64) 6.39  (4.46) U = –3.021 .003**
Specific Depression 5.07  (3.81) 5.78  (4.00) t(75) = –0.790 .432
Differential Score 1.56  (4.24) –0.61  (3.76) t(75) = 2.359 .021*
General Anxiety 3.44  (3.50) 6.36  (4.56) U = –3.166 .002**
General Depression 4.59  (3.64) 5.44  (3.72) t(75) = –1.021 .310
Note. The higher the score, the higher the identification with the variable.
*p ≤ .05. ** p < .01.
Table 4
Analysis of Items of the Leeds Anxiety and Depression Scales Measured in Relatives One Year After Surgery of Transplant
Patients 
Post-Transplant Anxiety
Low High                    
Items from Leeds Anxiety and Depression Scales M   (SD)             M (SD)     Value of Mann-Whitney U Statistic p
I get frightened or panic feelings for apparently 
no reason at all 0.39  (0.70) 0.86  (0.99) –2.314 .021*
I still enjoy the things I used to ♦ 0.39  (0.66) 0.75  (0.80) –2.226 .026*
I am restless and can’t keep still 0.66  (0.72) 1.19  (0.95) –2.258 .011*
I am more irritable than usual 0.95  (0.99) 1.50  (1.02) –2.311 .021*
I feel in some way to blame for the way I am 0.66  (0.88) 1.22  (1.14) –2.212 .027*
I get bad headaches 0.68  (0.75) 1.19  (0.98) –2.327 .020*
I get palpitations or a sensation of “butterflies” 
in my stomach or chest 0.73  (0.89) 1.28  (1.11) –2.225 .026*
I often think that I have done wrong 0.66  (0.96) 1.22  (1.09) –2.441 .015*
I feel scared or frightened 0.32  (0.68) 0.78  (0.92) –2.594 .009**
I feel tense or wound up 0.78  (0.88) 1.58  (1.02) –3.379 .001**
Note. Higher scores indicate higher degree of agreement with the item (except for the item marked with ♦, where a lower score
indicates more agreement) and poorer adjustment.
*p ≤ .05. **p < .01.
anxiety experienced stronger feelings and sensations of
panic, fear, depression and tension one year later (see
Table 2).
In the patients’ relatives, the following variables reached
significance: total anxiety-depression score, specific anxiety,
differential score, and general anxiety. In all of them (except
for the differential score), the relatives of the high-post-
transplantation anxiety patients scored significantly higher
than the low-anxiety group (see Table 3). We analyzed all
the items of the Leeds Anxiety and Depression Scales to
detect the items with more relevance in these differences.
As in the group of patients, here also, the items with the
highest significance were related to the emotional sphere.
Specifically, the relatives of the high post-transplantation
anxiety patients experienced more anxiety and feelings of
fear one year later (see Table 4). 
Discussion
In this investigation, we analyzed psychological
differences in patients and their relatives as a function of
the post-transplantation anxiety experienced one year ago
by the patients themselves. 
Psychological differences (anxiety, depression, and quality
of life) in patients as a function of their post-transplantation
anxiety one year ago. Once the patients had undergone
surgery and were discharged from the ICU, they had to
remain hospitalized for some time in the Transplantation
Unit of the hospital. The patients who, while in that unit,
displayed higher levels of anxiety also displayed more
anxious and depressive symptoms and had poorer quality of
life at one-year follow-up. Mainly, four areas are affected:
(a) psychological area: on the one hand, the patients displayed
more anxious symptomatology (“I feel tense or wound up,”
“I get a sort of frightened feeling as if something awful is
about to happen,” “worrying thoughts go through my mind,”
“I feel restless as if I have to be on the move,” and “I get
sudden feelings of panic.”) And on the other hand, they have
more depressive symptomatology (“I feel depressed,” “I do
not feel cheerful,” “I do not look forward with enjoyment
to things”); (b) social area: their physical state or the treatment
“affect their family life and their social activities negatively”;
(c) physical area: they usually suffer from more digestive
pathologies (for example, constipation); and (d) financial
area: they usually have more “financial problems.”
A possible explanation for these results may be that
people who have recently undergone organ transplantation
and who have a high level of anxiety are hypersensitive,
that is, they are more concerned about minor bodily signs
that would normally go unnoticed. In short, this emotional
state can generate thoughts of excessive concern, for
example, about the possibility of suffering organ rejection
or an infection, which do not favor their long-term
psychological and physical status. On the other hand, the
anxious symptomatology may increase their lack of
adherence to therapy, that is, their own psychological status
will lead them to ignore health habits, which, in turn, would
justify their having poorer quality of life one year after
undergoing transplantation surgery  (Dew et al., 2001; Dew,
Switzer, et al., 2000; Owen et al., 2006).
In short, for some transplant patients, the threat of the
loss of the transplanted organ, the constant or periodical
symptoms associated with the secondary effects of
immunosupressors, and the reminder of the diet or the
medication are risk factors for their adaptation, both personal
as well as social and family, although the affected individual
may conceal this from others, especially from healthcare
personnel (Magaz, 2006). Because of this, professionals
must make an effort to detect patients with higher levels of
post-transplantation anxiety, because negative emotional
states could be the sole factor that most affects their quality
of life after satisfactory organ transplantation (De Vito, Dew,
& Stilley, 2003). Therefore, it is appropriate to perform
psychotherapeutic interventions to prevent illness, enhance
reincorporation to work (which would also eliminate some
financial problems), improve social support and, especially,
increase adherence to medical treatment in order to preserve
the function of the grafted organ (Valdés & Ortega, 2006).
In accordance with this, the group of female transplant
patients deserves special attention, especially if they must
combine care of the implant with their desire to have
children (Casanovas & Cabré, 2007).
Psychological differences (anxiety, depression) in the
relatives as a function of patients’ previous post-
transplantation anxiety. The transplant process also affects
the family. Thus, for example, if after transplant, patients
do not feel well psychologically, that is, they have a high
level of anxiety, then they will probably transmit this
psychological distress to their relatives, so that the latter
will also display more anxious symptomatology: “they get
frightened or panic feelings no apparently no reason at all,”
“they no longer enjoy the things they used to,” “they feel
restless and can’t keep still,” “they are more irritable than
usual,” “they feel in some way to blame for the way they
are,” “they get bad headaches,” “they get palpitations, or a
sensation of ‘butterflies’ in the stomach or chest,” “they
often think they have done wrong,” “they feel scared or
frightened,” and “they are tense or wound up.” 
A possible explanation for these differences is that the
relatives think that, due to the patients’ psychological status,
their physical evolution may be poor, to the point of rejecting
the organ, and this has a negative effect on the relatives’
own mood (Pérez, Martín, & Pérez, 2005). On the other
hand, it should be taken into account that the family requires
support to cope with a series of stressors that usually appear
after transplantation, for example, fear of the patient’s death,
the feeling that nobody is interested in the patient or his/her
health, financial problems, and fear about whether the organ
will work. If the family does not receive such support from
their transplanted relative because the latter’s level of anxiety
prevents him/her from providing emotional, instrumental,
and informational aid, then the family also suffers an increase
of psychological disorders (Collins et al., 2000). 
This mood of the family harms their transplanted relative,
mainly because it prevents them from offering support. As
a consequence, this increases the patients’ psychological
disorders and leads them to ignore medical prescriptions
(Frazier et al., 2000; Pérez et al., 2000). In fact, in an
investigation carried out with liver-transplant patients, it was
verified that the patients who were in contact with depressive
relatives presented more anxious symptomatology (Pérez et
al., 2004).
Given that the psychological differences, not only in the
patients but also in their closest relatives, could derive from
post-transplantation anxiety, a series of psychotherapeutic
strategies should be carried out in transplanted patients so
that both they and their relatives could have the best quality
of life possible, both at short and at long term.  
We would like to point out the main limitation of this
study that should be taken into account in future research.
Specifically, a more exhaustive control of some
sociodemographic and clinical variables should be undertaken
in order to obtain groups as homogeneous as possible. 
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